Company / Current Assets per Share
Kura Oncology, Inc. Current Assets per Share History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Current Assets per Share
$9.06
FY2025
5-year range
$5.91 / $10.02
FY2021-FY2025
Trend
-9.6%
vs FY2024
Sector context
#83 of 210
Health Care
What the data says
At $9.06, Kura Oncology, Inc.'s current assets per share ranks #83 of 210 in the Health Care sector. Current Assets per Share has fluctuated over the past 10 years, ranging from $3.68 in FY2016 to $12.01 in FY2020.
Based on SEC 10-K filings.
9.06 in FY2025 with a 5-year CAGR of -5.5%.
Improved from $5.91 to $9.06 over the past 2 years.
Health Care sector context is included.
Current Assets per Share over time
Growth rates
- 3-Year CAGR
- +10.8%
- 5-Year CAGR
- -5.5%
- 10-Year CAGR
- -
Sector benchmark
#83 of 210 in Health CareTop 40% of 210This company $9.06 Sector average $170.65
▼
-94.7% below sector average
Key checks
Key Insights
- In FY2025, current assets per share decreased 9.6% year-over-year.
- Ranks #83 out of 210 companies in the Health Care sector.
- Peak current assets per share was recorded in FY2020.
- Lowest current assets per share in the period was in FY2016.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score -1.83 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Current Assets per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $9.06 | -9.6% |
| FY2024 | $10.02 | +69.6% |
| FY2023 | $5.91 | -11.4% |
| FY2022 | $6.66 | -15.3% |
| FY2021 | $7.87 | -34.4% |
| FY2020 | $12.01 | +110.2% |
| FY2019 | $5.71 | +10.9% |
| FY2018 | $5.15 | +26.4% |
| FY2017 | $4.07 | +10.7% |
| FY2016 | $3.68 | -57.9% |
As of FY2025 · SEC 10-K · Updated Mar 28, 2026